Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - ARS Pharmaceuticals, Inc. | StockGist | StockGist

Companies
SPRY
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings SPRYSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

ARS Pharmaceuticals, Inc.

Filed Mar 31, 2026

Accepted Mar 31, 2026, 6:43 PM ET

CIK 0001671858

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ARS Pharmaceuticals, Inc.

Person Type

OO

Amendment History

2 filings

SCHEDULE 13G
Original
Mar 24, 20260001104659-26-033875
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Mar 31, 20260001104659-26-037977

Recent Filings

ARS Pharmaceuticals, Inc.1 weeks ago

ARS Pharmaceuticals, Inc.3 weeks ago

ARS Pharmaceuticals, Inc.3 weeks ago

ARS Pharmaceuticals, Inc.1 months ago

ARS Pharmaceuticals, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice